Facebook
Twitter
LinkedIn
ForwardLive Team Training for Parkinson's 2025
Overview
Welcome to Live Team Training for Parkinson's 2025.
This course contains all live day evaluations as well as credit claiming. Please enroll in this course as you have the prerequisites, and prepare to have this course available at the end of your live team training days.
After the end of the final day of team training, you will be directed back here to claim your credits and certificate.
Syllabus | |
Live Day 1 - October 20th, 2025 Live Day 2 - October 21st, 2025 Live Day 3 - October 22nd, 2025 | |
Target Audience
This activity is designed to meet the educational needs of:
- Physicians
- Physician Assistants
- Nurses
- Physical Therapists
- Occupational Therapists
- Psychologists
- Social Workers
- Speech Language Pathologists
Learning Objectives
At the end of this activity, learners will be able to:
- Differentiate between the clinical characteristics of early, mid, and late stages of Parkinson’s disease to guide appropriate care interventions.
- Apply team care strategies to support individuals with Parkinson’s and their care partners in improving self-management and quality of life.
- Engage in interprofessional collaboration to optimize care coordination and improve outcomes for people with Parkinson’s and their care partners.
- Strengthen interprofessional networks and community partnerships to enhance the delivery of comprehensive team-based care.
Commercial Support Disclosure:
This activity is supported by an educational grant from Amneal Pharmaceuticals, Inc.
Program
Faculty & Planning Committee
Parkinson’s Foundation adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty
- Elaine Book, MSW, RSW: has no relevant financial relationships to disclose
- Gila Bronner, MPH, MSW: has no relevant financial relationships to disclose
- Lucille Carriere, PhD: has no relevant financial relationships to disclose
- Silke Cresswell: has disclosed that she has received financial support (Site Principal Investigator) from Praxis, AbbVie and (Speaker's Bureau) Merz Pharma.
- Joellyn Fox, PT, DPT: has no relevant financial relationships to disclose
- Darla Freeman, MA, CCC-SLP: has no relevant financial relationships to disclose
- Jennifer Goldman, MD, MS: has disclosed that she is a consultant for Acadia, CuraSen Therapeutics, GE Healthcare and NeuroPath; is on the Advisory Board for Sage, Roche, KeifeRX, EIP Pharma; has received research/grand support form Acadia.
- Charlene Heavener, RN: has no relevant financial relationships to disclose
- Josn Hlas, MSW, LISW: has no relevant financial relationships to disclose
- Jenna Iseringhausen, BSN, RN: has no relevant financial relationships to disclose
- Denise Kornegay MSW: has no relevant financial relationships to disclose
- Irene Litvan, MD: has disclosed that she has received financial support (Site Principal Investigator/Principal Investigator) from Abbott Pharmaceuticals' AbbVie Pharmaceuticals; Alterity Therapeutics, Amneal Pharmaceuticals, EIP Pharma, Inc., Lundbeck, Novartis, Roche Pharmaceutical, Transposon Therapeutics, UCB.
- Lori McManus, OTR/L: has no relevant financial relationships to disclose
- Joan Miravite, DNP, MSN, RN, FNP-BC: has disclosed that she has is a consultant for Abbott and Medtronic.
- John Morgan, MD, PhD: has disclosure that he is a Consultant for Amneal Pharmaceuticals, Biogen, Eisai, Kyowa Kirian; the recipient of Grant/Research support from Addex, Axsome, Bukwang, Cerevel, Neuraly, Pharma2b, Roche Diagnostics, Takeda, UCB; is on a Speaker' Bureau for Amneal, Biogen, Kyowa Kirin.
- Sotirios Parashos, MD: has disclosed that he has is a grant recipient/researcher support for Bukwang Pharmaceutical, Inhibikase Pharmaceutical, Intra-Cellular Therapies, Neuraly, SunPharma, UCB, Abbvie, Amnion, NeuroGlove and has a stockholder of Abbott Laboratories.
- Julia Wood, MOT, OTR/L: has no relevant financial relationships to disclose
Patient and Care Partner Faculty/Panel Member(s)
- All Patient and Care Partners have no relevant financial relationships to disclosure
Content Validator(s)
- Elaine Book, MSW, RSW: has no relevant financial relationships to disclose
- Nina Browner, MD: has no relevant financial relationships to disclose
- Lucille Carriere, PhD: has no relevant financial relationships to disclose
- Joellyn Fox, PT, DPT: has no relevant financial relationships to disclose
- Charlene Heavener, RN: has no relevant financial relationships to disclose
- Joan Hlas, MSW, LISW: has no relevant financial relationships to disclose
- Jenna Iseringhausen, BSN, RN: has no relevant financial relationships to disclose
- Lissa Kapust, LICSW: has no relevant financial relationships to disclose
- Miriam Rafferty, PT, DPT, PhD: has no relevant financial relationships to disclose
- Rachel Rose, OTR/L: has no relevant financial relationships to disclose
- Julia Wood, MOT, OTR/L: has no relevant financial relationships to disclose
- Erika Jacumin, PA-C: has no relevant financial relationships to disclose
- Corrine Jones, CCC-SLP: has no relevant financial relationships to disclose
Planning Committee(s)
- Elaine Book MSW, RSW: has no relevant financial relationships to disclose
- Nina Browner, PhD: has no relevant financial relationships to disclose
- Lucille Carriere: has no relevant financial relationships to disclose
- Heather Cianci, PT, MS, GCS: has no relevant financial relationships to disclose
- Darla Freeman, MA, CCC-SLP: has no relevant financial relationships to disclose
- Jennifer Goldman, MD, MS: has disclosed that she is a consultant for Acadia, CuraSen Therapeutics, GE Healthcare and NeuroPath; is on the Advisory Board for Sage, Roche, KeifeRX, EIP Pharma; has received research/grand support form Acadia.
- Erika Jacumin PA-C: has no relevant financial relationships to disclose
- Denise Kornegay MSW: has no relevant financial relationships to disclose
- Joan Miravite, DNP, MSN, RN, FNP-BC: has disclosed that she has is on a speaker’s bureau for Abbott, and is a consultant for Medtronic.
- Julia Wood, MOT, OTR/L: has no relevant financial relationships to disclose
- Sotirios Parashos, MD: has disclosed that he has is a grant recipient/researcher support for Bukwang Pharmaceutical, Inhibikase Pharmaceutical, Intra-Cellular Therapies, Neuraly, SunPharma, UCB, Abbvie, Amnion, NeuroGlove and has a stockholder of Abbott Laboratories.
Planner(s)
- Denise Beran: has no relevant financial relationships to disclose
- Elizabeth Pollard: has no relevant financial relationships to disclose
Accreditation
In support of improving patient care, Parkinson's Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 27.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
Parkinson’s Foundation designates this blended activity for a maximum of 27.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Parkinson’s Foundation has been authorized by the American Nurses Credentialing Center (ANCC) to award CNE credit. This activity is designated for 27.00 CNE credits. Participants should only claim credit commensurate with the extent of their participation.
Physician Assistants
Parkinson’s Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 27.00 AAPA Category 1 CME credits. Approval valid through October 24, 2027. PAs should only claim credit commensurate with the extent.
Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. 27.00 CE hours.
Social Workers
As a Jointly Accredited Organization, Parkinson’s Foundation is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Parkinson’s Foundation maintains responsibility for this course. Social workers completing this course receive 27.00 ASWB credits continuing education credits.
Occupational Therapists/Occupational Therapy Assistants
This course is approved by the Florida Board of Occupational Therapy.
Effective date:04/16/2025
OT General: 27.00
OTA General: 27.00
CE Broker Tracking #: 20-1280709
Provider Tracking #: 50-25705
Physical Therapists (Pending)
Speech-Language Pathologists
LSVT Global is approved by the Continuing Education Board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology and audiology. This course is offered for up to 2.6 continuing maintenance hours.
This event is offered for up to 2.6 ASHA CEUs (Advanced level; Professional area).
Available Credit
- 27.00 AAPA Category I CME
- 27.00 AMA PRA Category 1 Credit™
- 27.00 ANCC
- 27.00 APA
- 2.60 ASHA CE
- 27.00 ASWB ACE
- 27.00 IPCE Credit™
- 27.00 Occupational Therapist
- 27.00 Participation
- 27.00 Physical Therapist